These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16357789)
1. Patterns of prescription of hypoglycaemic drugs in Gran Canaria (Canary islands, Spain) and estimation of the prevalence of diabetes mellitus. de Pablos-Velasco PL; Martínez-Martín FJ; Molero R; Rodríguez-Perez F; García-Puente I; Caballero A Diabetes Metab; 2005 Nov; 31(5):457-62. PubMed ID: 16357789 [TBL] [Abstract][Full Text] [Related]
2. A prevalence study of known diabetes mellitus in Tuscany assessed from pharmaceutical prescriptions and other independent sources. Di Cianni G; Benzi L; Giannarelli R; Orsini P; Villani G; Ciccarone AM; Cecchetti P; Fedele O; Navalesi R Acta Diabetol; 1994 Jun; 31(2):87-90. PubMed ID: 7949228 [TBL] [Abstract][Full Text] [Related]
3. [Drug consumption in diabetes mellitus (I). Estimate of the therapeutic profile and the prevalence in the regions of Tarragona (548,900 inhabitants). Grup per a l'Estudi de la Diabetis a Tarragona]. Costa B; Utgés P; Monclús JF; Gomis T; Ciurana MR; Julve P Med Clin (Barc); 1992 Sep; 99(8):294-9. PubMed ID: 1453822 [TBL] [Abstract][Full Text] [Related]
4. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus]. Ozawa H; Murai Y; Ozawa T Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054 [TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Boronat M; Varillas VF; Saavedra P; Suárez V; Bosch E; Carrillo A; Nóvoa FJ Diabet Med; 2006 Feb; 23(2):148-55. PubMed ID: 16433712 [TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus in north Sweden: prevalence assessed from prescriptions for anti-diabetic agents. Forrest RD J Intern Med; 1990 Sep; 228(3):267-73. PubMed ID: 2205705 [TBL] [Abstract][Full Text] [Related]
7. [Prevalence of diabetes treated with drugs in Andalucía. Evolution of the oral antidiabetics and insulin prescription between 1994 and 2000]. Torrecilla Rojas MA; Ríos Bonin C; Fernández Fernández I Rev Clin Esp; 2003 Sep; 203(9):426-9. PubMed ID: 14563255 [TBL] [Abstract][Full Text] [Related]
8. [Prevalence and consumption of medication in diabetes mellitus in Madrid (1996-2002)]. Arrieta FJ; Calvo MJ; Peréz A; Saavedra P; Cordobés FJ; Cabral R; Arrieta JJ; Rovira A Rev Clin Esp; 2006 Mar; 206(3):117-21. PubMed ID: 16597376 [TBL] [Abstract][Full Text] [Related]
9. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy. Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and association of co-morbidities in diabetic patients along with prescription patterns in Delhi-NCT, India. Saxena T; Malhotra M; Yadav RK; Gupta SK Diabetes Metab Syndr; 2019; 13(2):1209-1212. PubMed ID: 31336466 [TBL] [Abstract][Full Text] [Related]
11. [Drug prescriptions and demographic indicators in a diabetic population in Argentina]. Quaglia NB; Nuñez MH; Marzi MM Farm Hosp; 2012; 36(2):92-6. PubMed ID: 22047667 [TBL] [Abstract][Full Text] [Related]
12. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk. Lorenzo V; Boronat M; Saavedra P; Rufino M; Maceira B; Novoa FJ; Torres A Nephrol Dial Transplant; 2010 Jul; 25(7):2283-8. PubMed ID: 20064954 [TBL] [Abstract][Full Text] [Related]
13. Changes in diabetes prevalence and treatment in the last ten years in Luxembourg. A lesson from the United Kingdom prospective diabetes study? Perquin M; Michel GH; de Beaufort C; Keipes M; Wirion R; Haas N Diabetes Metab; 2005 Nov; 31(5):499-502. PubMed ID: 16357795 [TBL] [Abstract][Full Text] [Related]
14. The incidence of skin melanoma in Gran Canaria (Canary Islands, Spain) is lower than expected in Southern Europe despite high-risk environmental conditions: an island-wide cross-sectional study. Grau-Pérez M; Carretero G; Almeida P; Castro-González E; de-la-Rosa-Del-Rey MDP; González-Martín JM; Borrego L Cancer Causes Control; 2021 May; 32(5):525-535. PubMed ID: 33646461 [TBL] [Abstract][Full Text] [Related]
15. Prescription of insulin glargine in primary care practices in Germany. Rathmann W; Haastert B; Riebel P; Schroeder-Bernhardi D; Kostev K; Huppertz E; Giani G Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):252-6. PubMed ID: 17479442 [TBL] [Abstract][Full Text] [Related]
16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
17. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Bode BW Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Boronat M; Chirino R; Varillas VF; Saavedra P; Marrero D; Fábregas M; Nóvoa FJ Diabet Med; 2005 Dec; 22(12):1751-6. PubMed ID: 16401323 [TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus: new drugs for a new epidemic. Nicholson G; Hall GM Br J Anaesth; 2011 Jul; 107(1):65-73. PubMed ID: 21610015 [TBL] [Abstract][Full Text] [Related]
20. Management of diabetes mellitus and patients' attitude towards the disease: Data from a nationwide study in Greece. Tentolouris A; Eleftheriadou I; Tzeravini E; Athanasakis K; Anastasiou IA; Kyriopoulos J; Tentolouris N Diabetes Metab Syndr; 2019; 13(2):1159-1164. PubMed ID: 31336459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]